David Rosen – ROIV history
- Issuer:
- ROIVANT SCIENCES LTD
- Quarters tracked:
- 15 (Q4 2022 → Q2 2026)
- Current shares:
- 6,000,000
- Current value:
- $212.34M
- Peak shares:
- 23,000,000 (Q2 2024)
- Overall change:
- +100%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 6,000,000 | $212.34M | $35.39 | +1,000,000 | +20% |
| Q1 2026 | 5,000,000 | $138.50M | $27.70 | -4,000,000 | -44% |
| Q4 2025 | 9,000,000 | $195.30M | $21.70 | -11,000,000 | -55% |
| Q3 2025 | 20,000,000 | $302.60M | $15.13 | -370,336 | -2% |
| Q2 2025 | 20,370,336 | $229.57M | $11.27 | +2,603,260 | +15% |
| Q1 2025 | 17,767,076 | $179.27M | $10.09 | -2,232,924 | -11% |
| Q4 2024 | 20,000,000 | $236.60M | $11.83 | -2,400,000 | -11% |
| Q3 2024 | 22,400,000 | $258.50M | $11.54 | -600,000 | -3% |
| Q2 2024 | 23,000,000 | $243.11M | $10.57 | +3,000,000 | +15% |
| Q1 2024 | 20,000,000 | $210.80M | $10.54 | +1,000,000 | +5% |
| Q4 2023 | 19,000,000 | $213.37M | $11.23 | +8,500,000 | +81% |
| Q3 2023 | 10,500,000 | $122.64M | $11.68 | +6,963,562 | +197% |
| Q2 2023 | 3,536,438 | $35.65M | $10.08 | -2,063,562 | -37% |
| Q1 2023 | 5,600,000 | $41.33M | $7.38 | +2,600,000 | +87% |
| Q4 2022 | 3,000,000 | $23.97M | $7.99 | — | NEW |